Terkko Navigator / richorn/ Feeds

AB12PHYLO: an integrated pipeline for Maximum Likelihood phylogenetic inference from ABI trace data

The spatiotemporal organization of experience dictates hippocampal involvement in primary visual cortical plasticity

Acid sphingomyelinase deactivation post-ischemia/ reperfusion promotes cerebral angiogenesis and brain remodeling via small extracellular vesicles

Acetylcholine boosts dendritic NMDA spikes in a CA3 pyramidal neuron model

Single Image-based Vignetting Correction for Improving the Consistency of Neural Activity Analysis in 2-Photon Functional Microscopy

Identification of the Rigid Core for Aged Liquid Droplets of the TDP-43 Low Complexity Domain

GMSECT: Genome-Wide Massive Sequence Exhaustive Com-parison Tool for structural and copy number variations

Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications

Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice

Corrigendum to: Pulmonary Hypertension in Heart Failure Patients

Determinants of Functional Capacity and Quality of Life After Implantation of a Durable Left Ventricular Assist Device

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition

Effects of Exercise Training on Cardiac Function in Heart Failure with Preserved Ejection Fraction

Gone, but not Forgotten

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure

Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives

Neprilysin as a Biomarker: Challenges and Opportunities

Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?

Morphine in the Setting of Acute Heart Failure: Do the Risks Outweigh the Benefits?

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart

Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019-associated Acute Respiratory Distress Syndrome: An Initial US Experience at a High-volume Centre

Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond

Mechanisms of Myocardial Injury in Coronavirus Disease 2019

Apps and Online Platforms for Patients with Heart Failure

Would You Prescribe Mobile Health Apps for Heart Failure Self-care? An Integrated Review of Commercially Available Mobile Technology for Heart Failure Patients

Cardiopulmonary Ultrasonography for Severe Coronavirus Disease 2019 Patients in Prone Position

Artificial Intelligence, Data Sensors and Interconnectivity: Future Opportunities for Heart Failure

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019

High-flow Nasal Cannula Oxygenation Revisited in COVID-19

Telemonitoring for the Management of Patients with Heart Failure

Telemonitoring in Heart Failure Management

Pulmonary Hypertension in Heart Failure Patients

Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure

The Use of App-based Follow-up of Cardiac Implantable Electronic Devices

Temporary Mechanical Circulatory Support in Acute Heart Failure

Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction

Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time

Red Cell Volume Distribution Width as Another Biomarker

Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?

Sodium-Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes

Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan

State-of-the-art Structural Interventions in Heart Failure

Right Ventricular Failure: Pathophysiology, Diagnosis and Treatment

Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice

Hyperkalemia and Renin-Angiotensin-Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

Foreword

Diet, the Gut Microbiome and Heart Failure